2 news items
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
OCUL
4 Jun 24
agreed to grant inducement awards to (i) its newly appointed Chief Medical Officer, Nadia K. Waheed, MD, MPH, and (ii) six other newly hired employees
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
OCUL
6 May 24
) its newly appointed Vice President, Head of Biostatistics, Zhongwen "Justin" Tang, Ph.D.; and (iii) eleven other newly hired employees. The awards were
- Prev
- 1
- Next